Can Huntington's disease clinical trial design tweaks lead to success?
After a series of disappointing clinical trial data in Huntington’s disease, study design changes take aim at moving the field forward.
Neurocrine Biosciences Prilenia Hayden Annexon Biosciences Prelinia Hayden Christopher Ross Lundbeck Xenazine
Source: clinicaltrialsarena.com